Trial intelligence / Profile preview

Cymenol Mouthwash for Dental Plaque

NCT05521230Phase 1Completed

Sponsor
Universidad de Santiago de Compostela
Start
Sep 2021
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in dental plaque comparing Placebo with Cymenol (2 arms). Primary endpoints: Change in the plaque area at 4 days and Change in the growth rate of dental plaque area at 4 days. Started Sep 2021; status: completed.

02

Drugs

o-Cymen-5-ol
03

Conditions

dental plaque

Beyond the preview

Go deeper on NCT05521230.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05521230.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call